Antivirale Nukleosid-Derivate

Patent europeic · EP0393920 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0393920
Numer da la dumonda
EP90303904
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
11-04-1990
Publitgà
24-10-1990
Concedì
09-07-1997
Stritgà
10-04-2010
Motiv
Durada maximala cuntanschida
Classas IPC
C07H 19/06 (2006.01)
C07D 473/00 (2006.01)
A61K 31/70 (2006.01)
A61K 31/52 (2006.01)
Prioritad
GB 8908646 17.04.1989
GB 8921266 20.09.1989
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 12-04-2010

    Durada maximala cuntanschida

    Published in Swissreg on 12.04.2010

  2. 31-10-2005

    Transferì

    Owner
    Scotia Holdings plc, Efamol House, Woodbridge Meadows, Guildford (Surrey GU1 1BA), United Kingdom → PROTARGA, INC., 2200 Renaissance Blvd., Suite 450, King of Prussia, PA 19406, USA

    Published in +pat+ No 20 in 2005

  3. 31-10-2005

    Transferì

    Owner
    PROTARGA, INC., 2200 Renaissance Blvd., Suite 450, King of Prussia, PA 19406, USA → Luitpold Pharmaceuticals, Inc., One Luitpold Drive, Shirley, NY 11967, USA

    Published in +pat+ No 20 in 2005

  4. 15-07-1997

    Represchentant inscrit

    Representative
    R. A. Egli & Co., Patentanwälte, Horneggstrasse 4, 8008 Zürich

    Published in PIDTJ No 13 in 1997

  5. 15-07-1997

    Concedì

    Published in PIDTJ No 13 in 1997

Partidas

Inventur

Horrobin, David Frederick, Scotia

Guildford, Surrey GU1 1BA, GB

Stewart, John Charles Marshall, Scotia

Guildford, Surrey GU1 1BA, GB

Winther, Michael David, Scotia

Guildford, Surrey GU1 1BA, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.